title: Predicting response to statins by pharmacogenetic testing.
authors.affiliation: Faculty of Pharmacy, University of Sydney, Australia. ingrid.gelissen@sydney.edu.au
authors.forename: Ingrid C
authors.initials: IC
authors.lastname: Gelissen
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Brown
mesh_terms: D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters / Q000235:genetics; D054316:Biomarkers, Pharmacological; D008078:Cholesterol, LDL / Q000378:metabolism*; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000235:genetics; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D027381:Liver-Specific Organic Anion Transporter 1; D009363:Neoplasm Proteins / Q000235:genetics; D027361:Organic Anion Transporters / Q000235:genetics; D010597:Pharmacogenetics
chemical_list: C116614:ABCG2 protein, human; D000070997:ATP Binding Cassette Transporter, Subfamily G, Member 2; D018528:ATP-Binding Cassette Transporters; D054316:Biomarkers, Pharmacological; D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D027381:Liver-Specific Organic Anion Transporter 1; D009363:Neoplasm Proteins; D027361:Organic Anion Transporters; C503999:SLCO1B1 protein, human; C553220:HMGCR protein, human; D006903:Hydroxymethylglutaryl CoA Reductases